ARMEN GARO H 4

What Happened
Garo H. Armen, Chairman, Chief Executive Officer and Principal Financial Officer of Agenus Inc. (AGEN), received 3,403 shares of common stock on April 17, 2026 as payment of salary in lieu of cash. The shares were issued at $4.79 per share (closing price on April 17), for a total value of approximately $16,300, and are reported as fully vested on the date of issuance.

Key Details

• Transaction date: April 17, 2026; Form 4 filed April 21, 2026. (The filing was four days after the transaction; Form 4s are typically due within two business days, so this appears to be late.)
• Price/value: $4.79 per share; total reported value ≈ $16,300.
• Shares received: 3,403 (reported as an award/grant/acquisition — code A).
• Shares owned after transaction: Not specified in the filing.
• Notable footnotes:
  • Shares were issued as salary with Compensation Committee approval and represent the net amount of pay for the period ending April 17, 2026; issued under the 2019 Equity Incentive Plan and fully vested on issuance.
  • Shares are held in Dr. Armen’s IRA accounts.
  • Dr. Armen is trustee and has investment authority for a GRAT holding 23,950 shares and is a general partner in Pixie Partners, which owns 5,000 shares; he disclaims beneficial ownership to the extent of his pecuniary interest in Pixie.

Context
This was compensation paid in stock (an award), not an open-market purchase or sale — a routine way for companies to pay executives and generally not a direct market-timing signal. The filing notes the transaction is payroll-related and fully vested at issuance.